Clinical Connection

@ClinConnection

ClinicalConnection Helps Connect You With Clinical Trials! Visit To Start Your Search!

Vrijeme pridruživanja: kolovoz 2017.

Tweetovi

Blokirali ste korisnika/cu @ClinConnection

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @ClinConnection

  1. 4. velj

    Positive results for anifrolumab in phase III SLE trial

    Poništi
  2. 4. velj

    Lenalidomide added to standard intensive treatment for older patients with AML and high-risk MDS

    Poništi
  3. 3. velj

    Phase I/II study of carfilzomib, bendamustine, and dexamethasone (CBD) in patients with newly diagnosed multiple myeloma

    Poništi
  4. 3. velj

    Photodynamic therapy in oral lichen planus: A prospective case-controlled pilot study

    Poništi
  5. 1. velj

    Multi-drug therapy for epilepsy influenced bispectral index after a bolus propofol administration without affecting propofol’s pharmacokinetics: a prospective cohort study

    Poništi
  6. 31. sij

    CD19/CD22 chimeric antigen receptor T-cell therapy for refractory acute B-cell lymphoblastic leukemia with FLT3-ITD mutations

    Poništi
  7. 31. sij

    CD40 blockade shows promise in pSS trial

    Poništi
  8. 29. sij

    Room for improvement in clinical trials for rare diseases

    Poništi
  9. 28. sij

    Dose escalation prophylactic donor lymphocyte infusion after T-cell depleted matched related donor allogeneic hematopoietic cell transplantation is feasible and results in higher donor chimerism, faster immune re-constitution, and prolo...

    Poništi
  10. 27. sij

    Are electronic health records ready for clinical trial use?

    Poništi
  11. 24. sij

    LRRK2 in Parkinson disease: challenges of clinical trials

    Poništi
  12. 20. sij

    Safety and feasibility of anti-CD19 CAR T cells with fully human binding domains in patients with B-cell lymphoma

    Poništi
  13. 17. sij

    A prospective evaluation on the interaction of fluconazole and voriconazole on serum concentrations of budesonide in patients treated for gastrointestinal GVHD

    Poništi
  14. 13. sij

    Decision-analytic modeling as a tool for selecting optimal therapy incorporating hematopoietic stem cell transplantation in patients with hematological malignancy

    Poništi
  15. 10. sij

    R-CHOP can be safely de-escalated in NHL

    Poništi
  16. 10. sij

    Dissecting the mechanisms of immune checkpoint therapy

    Poništi
  17. 10. sij

    Clonal kinetics and single-cell transcriptional profiling of CAR-T cells in patients undergoing CD19 CAR-T immunotherapy

    Poništi
  18. 8. sij

    Cenobamate for focal seizures — a game changer?

    Poništi
  19. 7. sij

    Evolution in upfront treatment strategies for metastatic RCC

    Poništi
  20. 6. sij

    Effective delivery of Complex Innovative Design (CID) cancer trials—A consensus statement

    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·